Biomerica (NASDAQ:BMRA) Releases Earnings Results

Biomerica (NASDAQ:BMRA) released its quarterly earnings data on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, Zacks reports. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

Biomerica Trading Up 6.8 %

Shares of BMRA opened at $0.35 on Thursday. The firm’s 50-day moving average is $0.33 and its two-hundred day moving average is $0.34. Biomerica has a twelve month low of $0.24 and a twelve month high of $1.35. The firm has a market capitalization of $5.89 million, a P/E ratio of -0.95 and a beta of -1.04.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.